Akari Therapeutics, Plc
AKTX
$10.73
$1.2112.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.77M | 5.20M | 2.48M | 2.71M | 2.58M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 731.00K | 185.00K | 349.00K | 447.00K | 627.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 90.00K | 74.00K | 113.00K | 143.00K | 140.00K |
| Total Current Assets | 3.59M | 5.46M | 2.95M | 3.30M | 3.35M |
|
|
|||||
| Total Current Assets | 3.59M | 5.46M | 2.95M | 3.30M | 3.35M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | 8.43M | 8.43M | 8.43M | 8.43M |
| Goodwill | -- | 8.43M | 8.43M | 8.43M | 8.43M |
| Total Other Intangibles | 30.30M | 34.00M | 34.00M | 39.18M | 39.18M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 33.89M | 47.89M | 45.38M | 50.91M | 50.96M |
|
|
|||||
| Total Accounts Payable | 8.64M | 8.77M | 10.84M | 11.61M | 13.07M |
| Total Accrued Expenses | 3.33M | 2.34M | 1.62M | 2.47M | 3.49M |
| Short-term Debt | 732.00K | 754.00K | 2.12M | 1.55M | 1.85M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 714.00K | 485.00K | 984.00K | 1.52M | 2.50M |
| Total Other Current Liabilities | 714.00K | 485.00K | 984.00K | 1.52M | 2.50M |
| Total Current Liabilities | 13.42M | 12.35M | 15.57M | 17.14M | 20.91M |
|
|
|||||
| Total Current Liabilities | 13.42M | 12.35M | 15.57M | 17.14M | 20.91M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 732.00K | 754.00K | 2.12M | 1.55M | 1.85M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.09M | 7.21M | 7.12M | 8.17M | 8.31M |
| Total Liabilities | 19.51M | 19.56M | 22.69M | 25.31M | 29.21M |
|
|
|||||
| Common Stock & APIC | 234.81M | 234.32M | 230.89M | 227.37M | 221.28M |
| Retained Earnings | -279.01M | -264.55M | -259.25M | -252.85M | -250.96M |
| Treasury Stock & Other | 58.57M | 58.56M | 51.05M | 51.09M | 51.42M |
| Total Common Equity | 14.38M | 28.33M | 22.69M | 25.61M | 21.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.38M | 28.33M | 22.69M | 25.61M | 21.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14.38M | 28.33M | 22.69M | 25.61M | 21.75M |
|
|
|||||